Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Curosurf versus BLES for neonatal respiratory distress syndrome
IRCT20170513033941N54Phase 3Completed
- Sponsor
- Kashan University of Medical Sciences
- Start
- Apr 2018
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in respiratory distress syndrome (RDS) comparing Curosurf arm with BLES arm (2 arms). Primary endpoint: Number of surfactant injections. Started Apr 2018; status: completed.
02
Drugs
Poractant alfaBLES
03
Conditions
respiratory distress syndrome (RDS)
Beyond the preview
Go deeper on IRCT20170513033941N54.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20170513033941N54.